Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors

Oncology Reports

Volumn 15, Issue 3, 2006, Pages 589-594

  Wang, Changning ^a   Song, Yaling ^a   Peng, Bin ^a   Fan, Mingwen ^a   Li, Jiang ^b   Zhu, Shengrong ^c   Bian, Zhuan ^a  

^a WUHAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

c Src; Central giant cell granuloma; Cherubism; Giant cell tumor

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ISOENZYME; PROTEIN KINASE P60; TARTRATE-RESISTANT ACID PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; CHEMISTRY; CHILD; COMPARATIVE STUDY; FIBROUS DYSPLASIA; GENE EXPRESSION; GENETICS; GIANT CELL; GIANT CELL GRANULOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MIDDLE AGED; OSTEOCLASTOMA; PATHOLOGY;

ACID PHOSPHATASE; ADOLESCENT; ADULT; BONE NEOPLASMS; CHERUBISM; CHILD; GENE EXPRESSION; GIANT CELL TUMOR OF BONE; GIANT CELLS; GRANULOMA, GIANT CELL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOENZYMES; MIDDLE AGED; PROTO-ONCOGENE PROTEINS PP60(C-SRC);

EID: 33645734524     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.3.589     Document Type: Article

References (26)

1. Jones WA: Familial multilocular cysts of the jaws. Am J Cancer 17: 946-950, 1933.
2. Kramer IRH, Pindborg JJ and Shear M: World Health Organization Histological Typing of Odontogenic Tumors. 2nd edition. Springer-Verlag, Berlin, p31, 1992.
3. Lo B, Faiyaz-UI-Haque M, Kennedy S, Aviv R, Tsui LC and Teebi AS: Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism. Am J Med Genet 121A: 37-40, 2003. (Pubitemid 37059339)
4. Imai Y, Kanno K, Moriya T, Kayano S, Seino H, Matsubara Y and Yamada A: A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism. Cleft Palate Craniofac J 40: 632-638, 2003. (Pubitemid 37429693)
5. Özkan Y, Varol A, Turker N, Aksakalli N and Basa S: Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature. Int J Pediatr Otorhinolaryngol 67: 1005-1012, 2003. (Pubitemid 36952390)
6. Kaugars GE, Niamtu J and Svirsky JA: Cherubism: diagnosis, treatment, and comparison with central giant cell granulomas and giant cell tumors. Oral Surg Oral Med Oral Pathol 73: 369-374, 1992.
7. Itonaga I, Hussein I, Kudo O, Sabokbar A, Watt-Smith S, Ferguson D and Athanasou NA: Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw. J Oral Pathol Med 32: 224-231, 2003. (Pubitemid 36604018)
8. Robinson D, Segal M and Nevo Z: Giant cell tumor of bone: the role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis. Pathobiology 70: 333-342, 2002-03. (Pubitemid 36829008)
9. Oda Y, Sakamoto A, Saito T, Matsuda S, Tanaka K, Iwamoto Y and Tsuneyoshi M: Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation. Histopathology 39: 629-637, 2001. (Pubitemid 34019218)
10. Auclair PL, Cuenin P, Kratochvil FJ, Slater LJ and Ellis GL: A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor. Oral Surg Oral Med Oral Pathol 66: 197-208, 1988.
11. Liu B, Yu SF and Li TJ: Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med 32: 367-375, 2003. (Pubitemid 36781536)
12. Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E and Mariette X: RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol 117: 210-216, 2002. (Pubitemid 34823661)
13. Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D and Dougall WC: A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J Biol Chem 277: 44347-44356, 2002. (Pubitemid 36157870)
14. Xing L, Venegas AM, Chen A, Garrett-Beal L, Boyce BF, Varmus HE and Schwartzberg PL: Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival. Genes Dev 15: 241-253, 2001. (Pubitemid 32107668)
15. Kozakiewicz M, Perczynska-Partyka W and Kobos J: Cherubism-clinical picture and treatment. Oral Dis 7: 123-130, 2001.
16. Von Wowern N: Cherubism: a 36-year long term follow-up of 2 generations in different families and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90: 765-772, 2000.
17. Ongole R, Pillai RS and Pai KM: Cherubism in siblings: a case report. J Can Dent Assoc 69: 150-154, 2003.
18. Abram CL and Courtneidge SA: Review: Src family tyrosine kinases and growth factor signaling. Exp Cell Res 254: 1-13, 2000. (Pubitemid 30066726)
19. Verbeek BS, Vroom TM, Adriaansen-Slot SS, Geertzema JG, Ottenhoff-Kalff AE, Hennipman A and Rijksen G: C-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180: 383-388, 1996. (Pubitemid 27014075)
20. c-src protein kinase is an early event in colon carcinogenesis. Proc Natl Acad Sci USA 87: 558-562, 1990.
21. c-src in human small cell and non-small cell lung carcinomas. Eur J Cancer 28: 372-377, 1992.
22. Fanning P, Bulovas K, Saini KS, Libertino JA, Joyce AD and Summerhayes IC: Elevated expression of pp60c-src in low grade human bladder carcinomas. Cancer Res 52: 1457-1462, 1992.
23. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL and Boyle WJ: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97: 1566-1571, 2000. (Pubitemid 30118482)
24. Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature 423: 337-342, 2003. (Pubitemid 40852708)
25. Miyamoto N, Higuchi Y, Tajima M, Ito M, Tsurudome M, Nishio M, Kawano M, Sudo A, Uchida A and Ito Y: Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. J Orthop Res 18: 647-654, 2000.
26. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ and Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309, 1999. (Pubitemid 129516268)